Virtual Tumor Board: Hepato-Pancreato-Biliary Disease and COVID-19

Activity Description

The virtual tumor board discussion will include:

COVID-19 status at various facilities
Considerations for cases coming off therapy versus newly diagnosed
Role of neoadjuvant, chemotherapy and radiation therapy

The following cases will be discussed:

Pancreas cancer after planned 4 months of chemotherapy in borderline resectable disease
Colorectal liver metastases after 3 months of chemotherapy in a patient with previous primary resection at 6 months of chemotherapy
New resectable duodenal cancer

Moderators include Melissa Hogg, MD, Northshore University and Alexander Parikh, MD, East Carolina University. Panelists include surgical oncologists Flavio Rocha, MD, Virginia Mason Medical Center, Hari Nathan, MD, PhD, University of MI, Sepideh Gholami, MD UC Davis Health, Julie Hallet, MD, Sunnybrook Research Institute and medical oncologists, Michael Raphael, MD, Sunnybrook Research Institute, and Vincent Picozzi, Jr., MD, Virginia Mason Medical Center and radiation oncologists, Sten Myrehaug, MD, Sunnybrook Research Institute, Arta Monjazem, MD, PhD, UC Davis Health and Kyle Cuneo, MD, University of MI.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered